Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: A study of the Spanish Group for Research on Sarcomas (GEIS)

This publication has 20 references indexed in Scilit:

• Synovial sarcoma. Uniform response of metastases to high dose ifosfamide
  Cancer, 1994
• Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue
  The Lancet, 1994
• Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy
  Cancer Chemotherapy and Pharmacology, 1993
• Chemotherapy in the multidisciplinary approach to soft tissue sarcomas
  Annals of Oncology, 1992
• Fractionated ifosfamide therapy produces a time‐dependent increase in ifosfamide metabolism.
  British Journal of Clinical Pharmacology, 1990
• Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.
  Journal of Clinical Oncology, 1989
• Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomas
  European Journal of Cancer and Clinical Oncology, 1987
• Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557)
  Cancer, 1984
• High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma
  Cancer Chemotherapy and Pharmacology, 1983
• Reporting results of cancer treatment
  Cancer, 1981